<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00985075</url>
  </required_header>
  <id_info>
    <org_study_id>08-003-14</org_study_id>
    <nct_id>NCT00985075</nct_id>
  </id_info>
  <brief_title>A Pilot Study Evaluating the Signs and Symptoms of Seasonal Allergic Rhinoconjunctivitis Following Exposure in the Allergen BioCube</brief_title>
  <official_title>A Pilot Study Evaluating the Signs and Symptoms of Seasonal Allergic Rhinitis and Conjunctivitis Following Allergen Exposure in the Allergen BioCube</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ORA, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ORA, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate ocular and nasal signs and symptoms in patients
      with seasonal allergic rhinoconjunctivitis following allergen exposure in the Allergen
      BioCube.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Ocular Itching</measure>
    <time_frame>At specified timepoints for up to 3 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Conjunctival Redness</measure>
    <time_frame>At specified timepoints for up to 3 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Ocular Symptom Score (TOSS)of ocular itching and redness</measure>
    <time_frame>Not Specified</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Nasal Symptom Score (TNSS) of nasal symptoms</measure>
    <time_frame>Not Specified</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ciliary and episcleral redness</measure>
    <time_frame>At specified timepoints for up to 3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chemosis</measure>
    <time_frame>At specified timepoints for up to 3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lid Swelling</measure>
    <time_frame>At specified timepoints for up to 3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tearing</measure>
    <time_frame>At specified timepoints for up to 3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nasal Itching</measure>
    <time_frame>At specified timepoints for up to 3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sneezing</measure>
    <time_frame>At specified timepoints for up to 3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rhinorrhea</measure>
    <time_frame>At specified timepoints for up to 3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nasal Congestion</measure>
    <time_frame>At specified timepoints for up to 3 hours</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Allergic Rhinoconjunctivitis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects will be 18 years of age or older with a positive history of ocular and nasal
        allergy and a positive skin test reaction to one of the allergens tested within the past 24
        months
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  be at least 18 years of age;

          -  if female, cannot be pregnant or nursing;

          -  have a history of ocular and nasal allergy and a positive skin test reaction to one of
             the allergens tested within the past 24 months;

        Exclusion Criteria:

          -  have a history of mild persistent, moderate or severe asthma within the preceding 5
             years according to the National Heart, Blood and Lung Institute classification;

          -  have a compromised lung function;

          -  have any ocular condition that could affect the subject's health or the study
             parameters;

          -  have any presence of active ocular or sinus infection;

          -  have significant nasal conditions;

          -  have any significant illness that could be expected to interfere with the subject's
             health or with the study parameters

          -  use specified disallowed medications (topical, topical ophthalmic, systemic and/or
             injectable treatments and all anti-allergy therapies) during the study or appropriate
             pre-study washout period;

          -  have used an investigational drug or device within 30 days of starting the study or be
             concurrently enrolled in another investigational drug or device study within 30 days
             of the study;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Gomes, MS</last_name>
    <role>Study Director</role>
    <affiliation>ORA, Inc.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Henry J. Crampton, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>ORA, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ophthalmic Research Associates, Inc</name>
      <address>
        <city>Andover</city>
        <state>Massachusetts</state>
        <zip>01810</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 25, 2009</study_first_submitted>
  <study_first_submitted_qc>September 25, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 28, 2009</study_first_posted>
  <last_update_submitted>September 25, 2009</last_update_submitted>
  <last_update_submitted_qc>September 25, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 28, 2009</last_update_posted>
  <responsible_party>
    <name_title>H. Jerome Crampton, MD</name_title>
    <organization>Ophthalmic Research Associates</organization>
  </responsible_party>
  <keyword>Allergic rhinitis</keyword>
  <keyword>Allergic conjunctivitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Conjunctivitis</mesh_term>
    <mesh_term>Signs and Symptoms</mesh_term>
    <mesh_term>Conjunctivitis, Allergic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

